Effect of Adjuvant Homeopathy with Usual Care in Management of Thrombocytopenia Due to Dengue – a Comparative Cohort Study

Nayak, Debadatta; Chadha, Vishal; Jain, Shruti; Nim, Priyanka; Sachdeva, Jyoti; Sachdeva, Garima; Vivekanand, Kumar; Khurana, Anil; Manchanda, Raj K; Raheja, Sunil M.

doi:10.1055/s-0040-1702076

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 Notably, there is compelling anecdotal evidence associating homeopathy to the 1918 Spanish flu outbreak, highlighting lower mortality rates among patients treated with Gelsemium . 12 13 Clinical studies have demonstrated positive outcomes, such as thrombocytopenia improvement in dengue hemorrhagic fever 14 and reduced mortality in ACS. 15 However, it is crucial to conduct structured and internationally recognized clinical research to evaluate the efficacy and safety of customized homeopathic medications in treating and preventing the COVID-19 epidemic.…”

Section: Tablementioning

confidence: 99%

Brief Overview of Clinical Evidence for Homeopathic Interventions in the Management of COVID-19 Patients

Campos,

Silva,

Morais

et al. 2023

Homeopathy

View full text Add to dashboard Cite

show abstract

Section: Tablementioning

confidence: 99%

Brief Overview of Clinical Evidence for Homeopathic Interventions in the Management of COVID-19 Patients

Campos,

Silva,

Morais

et al. 2023

Homeopathy

View full text Add to dashboard Cite

show abstract

“…[16][17][18] The evidence for the effectiveness of these interventions is unclear, though studies have reported prophylactic effects in diseases such as chikungunya, 19 leptospirosis, 20 meningitis, 21 dengue, 22 and malaria. 23 Encouraging treatment results were also recorded in pneumonia, [24][25][26][27][28][29] cholera, 30 influenza (Spanish flu 1918, 31 swine flu 2009 32 ), influenza-like illness, 33 dengue, 34 and acute encephalitis syndrome. 35 Most of these were observational (case reports and cohort studies), with limited experimental studies.…”

Section: Repurposing Of Homeopathic Medicinesmentioning

confidence: 99%

Clinical Repurposing of Medicines is Intrinsic to Homeopathy: Research Initiatives on COVID-19 in India

2021

Self Cite

View full text Add to dashboard Cite

As at mid-October 2020, the coronavirus disease 2019 (COVID-19) pandemic has been continuing on the rise across the globe, including in India. Historically, homeopathy has been used in a number of epidemics/pandemics. The development of homeopathic medicines is approached uniquely through “drug provings” and clinical verification; these two intrinsic processes establish the background for the application of homeopathic medicines, regardless of nosological diagnosis. This article reflects research initiatives on COVID-19 in India and identifies studies listed in the Clinical Trial Registry–India database. We identified 29 studies being undertaken in different settings, including those in conventional medicine: 20 randomized controlled trials (RCTs) and 9 observational studies. Fifteen studies are aimed at prophylaxis and 14 are aimed at treatment. Amongst the treatment studies, 11 are focused on efficacy or comparative effectiveness. The findings might provide evidence for clinically repurposing some of homeopathy's medicines, an approach that is intrinsic to the therapy, enabling their use in COVID-19 as an adjuvant or stand-alone to help reduce costs and improve patient recovery.

show abstract

“…20 21 22 23 Different methods exist for employing homeopathic medicines in epidemic scenarios, which may involve individual administration, combination of remedies in complexes, preparation from the etiological agent itself (isotherapy or biotherapy) or identification of the so-called genus epidemicus 23 24 25 in which prevailing clinical manifestations in the majority of individuals afflicted by a specific infectious disease are considered to establish treatment protocols. 21 Presently, several reports suggest some efficacy of homeopathy in epidemic management, 24 25 26 27 28 29 yet uncertainties persist regarding SARS-CoV-2 due to its pleomorphism and significant mutational potential. 30 31 32…”

Section: Introductionmentioning

confidence: 99%

Prevalence of COVID-19 Complications during a Program of Homeopathic Camphora Officinalis Distribution to City Populations of Santa Catarina, Brazil: An Ecological Study

de Vilhena,

Coutracos,

Coimbra

et al. 2024

Homeopathy

View full text Add to dashboard Cite

Background Coronavirus disease 2019 (COVID-19), a disease caused by the SARS-CoV-2 coronavirus, was declared a pandemic in March 2020, posing significant challenges globally. Homeopathy has historical relevance in epidemic management. In response, the government of the state of Santa Catarina, Brazil, distributed Camphora 1M as a potential prophylactic intervention for COVID-19. Objective This study aimed to investigate the possible effects of Camphora 1M as an adjunctive prophylactic measure in managing COVID-19, focusing on mortality and hospitalization rates, during the period April 28 to July 31, 2020, within designated COVID-19 in-patient units in Santa Catarina. Methods An ecological study design was applied to this epidemiological research. Five case municipalities (Itajaí, Atalanta, Entre Rios, Rio do Campo, Trombudo Central) were compared with five control municipalities (São José, Galvão, Pedras Grandes, Grão-Pará, Ascurra). Results No statistically significant differences were observed in predictor variables between municipalities that received Camphora 1M and the respective controls. Similarly, no statistically significant differences were observed in outcomes: deaths (p = 0.879), hospitalized cases (p = 0.537), daily ward admissions (p = 0.730) and ICU admissions (p = 0.072). Conclusion For the first wave of the pandemic in the state of Santa Catarina, Brazil, city-wide distribution of Camphora 1M was not associated with reduced numbers, severity or mortality among the population hospitalized in designated public hospitals for COVID-19.

show abstract

Effect of Adjuvant Homeopathy with Usual Care in Management of Thrombocytopenia Due to Dengue – a Comparative Cohort Study

Cited by 4 publications

References 0 publications

Brief Overview of Clinical Evidence for Homeopathic Interventions in the Management of COVID-19 Patients

Brief Overview of Clinical Evidence for Homeopathic Interventions in the Management of COVID-19 Patients

Clinical Repurposing of Medicines is Intrinsic to Homeopathy: Research Initiatives on COVID-19 in India

Prevalence of COVID-19 Complications during a Program of Homeopathic Camphora Officinalis Distribution to City Populations of Santa Catarina, Brazil: An Ecological Study

Contact Info

Product

Resources

About